Clinical trials recruiting in Costa Rica
11
Recruiting trials
15
Conditions
3
Cities with sites
Phase breakdown
Phase 3 5Not applicable 6
Cities in Costa Rica
Conditions recruiting in Costa Rica
Recruiting trials in Costa Rica
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma
- INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
- Motiva Flora Tissue Expander PMCF
- Motiva Flora® Aesthetic Breast Recon® Clinical Study
- PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Common questions
How many clinical trials are recruiting in Costa Rica?
11 recruiting trials have at least one study site in Costa Rica.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.